Drug Trial Radar · NCT06047080
An Open-Label Study Comparing Glofitamab and Polatuzumab Vedotin + Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone Versus Pola-R-CHP in Previously Untreated Patients With Large B-Cell Lymphoma
Last checked: Nov 20, 2026Latest source record: Sep 11, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
1,130
Actual
Start
Sep 18, 2023
Primary completion
Oct 1, 2027
Study completion Oct 30, 2030
Sponsor
- Lead sponsor
- Hoffmann-La RocheRoche (Genentech) (RHHBY)
- Sponsor type
- Industry
- First posted
- Sep 21, 2023
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to compare the efficacy and safety of glofitamab in combination with polatuzumab vedotin plus rituximab, cyclophosphamide, doxorubicin, and prednisone (Pola-R-CHP) vs Pola-R-CHP in participants with previously untreated CD20-positive large B-cell lymphoma (LBCL).
Conditions
- Large B-Cell Lymphoma
Interventions
GlofitamabDrug
Participants will receive intravenous (IV) glofitamab
Polatuzumab vedotinDrug
Participants will receive IV polatuzumab vedotin in combination with R-CHP
RituximabDrug
Participants will receive IV rituximab
CyclophosphamideDrug
Participants will receive cyclophosphamide as part of CHP chemotherapy
DoxorubicinDrug
Participants will receive IV doxorubicin
PrednisoneDrug
Participants will receive oral prednisone as part of CHP chemotherapy
Primary outcomes
What the sponsor says the trial is designed to measure.
- Progression-free survival (PFS) as determined by Independent Review Facility (IRF)Time frame: From randomization to the first occurrence of disease progression or relapse, or death due to any cause, whichever occurs first (up to approximately 65 months)
Locations
229 sites in 21 countries. Site status is shown where the registry gives one.
Alaska Oncology & Hematology, LLC
Anchorage, Alaska
Kaiser Permanente - Anaheim (E. La Palma)
Anaheim, California
University of California, San Francisco-Fresno
Clovis, California
City of Hope National Medical Center
Duarte, California
City of Hope - Lennar Foundation Cancer Center
Irvine, California
Valkyrie Clinical Trials
Los Angeles, California
UCLA Jonsson Comprehensive Cancer Center
Los Angeles, California
Kaiser Permanente - Roseville
Roseville, California
Kaiser Permanente - Santa Clara
Santa Clara, California
Stanford Univ School of Med
Stanford, California
Kaiser Permanente Medical Ctr
Vallejo, California
University of Colorado Cancer Center
Aurora, Colorado
Rocky Mountain Cancer Center - Denver
Littleton, Colorado
Yale University School Of Medicine
New Haven, Connecticut
Medstar Franklin Square Medical Center
Washington D.C., District of Columbia
Miami Cancer Institute of Baptist Health, Inc.
Miami, Florida
Memorial Cancer Institute at Memorial West
Pembroke Pines, Florida
Hawaii Cancer Care
Honolulu, Hawaii
Robert H. Lurie Comprehensive Cancer Center of Northwestern University
Chicago, Illinois
Illinois Cancer Care
Peoria, Illinois
Springfield Clinic
Springfield, Illinois
University of Iowa
Iowa City, Iowa
Ascension Via Christi Research
Wichita, Kansas
Ochsner Medical Center
New Orleans, Louisiana
Massachusetts General Hospital
Boston, Massachusetts
Dana Farber Cancer Institute
Boston, Massachusetts
Boston Medical Center
Boston, Massachusetts
Henry Ford Health System
Novi, Michigan
M Health Fairview University of Minnesota Medical Center
Minneapolis, Minnesota
St. Luke's Hospital
Chesterfield, Missouri
Washington University School of Medicine
St Louis, Missouri
University of Nebraska Medical Center
Omaha, Nebraska
NYU Langone Hospital?Brooklyn
Brooklyn, New York
NYU Long Island Hospital
Mineola, New York
New York University Medical Center PRIME
New York, New York
Memorial Sloan Kettering Cancer Center David H Koch Center for Cancer Care
New York, New York
Weill Cornell Medical College-New York Presbyterian Hospital
New York, New York
University of Rochester Medical Center
Rochester, New York
North Shore Hematology Oncology Association PC
Shirley, New York
Montefiore Medical Center
The Bronx, New York
Showing 40 of 229 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.